Skip to main content
. 2020 Spring;19(2):9–21. doi: 10.22037/ijpr.2020.112291.13663

Table  2.

List of multivesicular particles (DepoFoam) drugs along with their half-life and route of administration

DepoFoam Against Subject Administration Half-life (h) Reference
Drug Active substance Encapsulated Unencapsulated
DepoCyt Cytarabine liposome Lymphomatous meningitis Human Intrathecal 82.4 3.4 (29)
DepoDur Morphine Pain Human Epidural 24-48 12-24 (2)
DepoDFO Desferrioxamine mesylate Iron overload Rat Subcutaneous 72 24 (43)
EXPAREL Liposomal Bupivacaine Pain Human Subcutaneous 96 24 (3, 48)
Dog Intravenous 1.11 0.473 (45)
Intra-arterial 0.539 0.26
DepoIGF-I Insulin-like growth factor I Hormonal disorder Rat Subcutaneous 26 4 (17)